Cargando…

EVs-mediated delivery of CB2 receptor agonist for Alzheimer's disease therapy

Alzheimer's disease (AD) is a typical neurodegenerative disease that leads to irreversible neuronal degeneration, and effective treatment remains elusive due to the unclear mechanism. We utilized biocompatible mesenchymal stem cell-derived extracellular vesicles as carriers loaded with the CB2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yanjing, Huang, Ruiqi, Wang, Deheng, Yu, Liqun, Liu, Yuchen, Huang, Runzhi, Yin, Shuai, He, Xiaolie, Chen, Bairu, Liu, Zhibo, Cheng, Liming, Zhu, Rongrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shenyang Pharmaceutical University 2023
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460952/ https://www.ncbi.nlm.nih.gov/pubmed/37645682 http://dx.doi.org/10.1016/j.ajps.2023.100835

Ejemplares similares

Combination therapy with ultrasound and 2D nanomaterials promotes recovery after spinal cord injury via Piezo1 downregulation
por: Zhang, Feng, et al.
Publicado: (2023)

Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression
por: He, Xiaolie, et al.
Publicado: (2016)

Neurogenesis potential of oligodendrocyte precursor cells from oligospheres and injured spinal cord
por: Zhao, Qing, et al.
Publicado: (2022)

Spinal cord injury: molecular mechanisms and therapeutic interventions
por: Hu, Xiao, et al.
Publicado: (2023)

MgFe‐LDH Nanoparticles: A Promising Leukemia Inhibitory Factor Replacement for Self‐Renewal and Pluripotency Maintenance in Cultured Mouse Embryonic Stem Cells
por: He, Xiaolie, et al.
Publicado: (2021)

DeepScreen: An Accurate, Rapid, and Anti‐Interference Screening Approach for Nanoformulated Medication by Deep Learning
por: Zhu, Yanjing, et al.
Publicado: (2018)

Deep learning-based predictive identification of neural stem cell differentiation
por: Zhu, Yanjing, et al.
Publicado: (2021)

Cancer Therapy: Anti‐Metastatic and Anti‐Angiogenic Activities of Core–Shell SiO(2)@LDH Loaded with Etoposide in Non‐Small Cell Lung Cancer (Adv. Sci. 11/2016)
por: Zhu, Yanjing, et al.
Publicado: (2016)

Anti‐Metastatic and Anti‐Angiogenic Activities of Core–Shell SiO(2)@LDH Loaded with Etoposide in Non‐Small Cell Lung Cancer
por: Zhu, Yanjing, et al.
Publicado: (2016)

Biocompatible exosome-modified fibrin gel accelerates the recovery of spinal cord injury by VGF-mediated oligodendrogenesis
por: He, Xiaolie, et al.
Publicado: (2022)

Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists
por: Navarro-Dorado, Jorge, et al.
Publicado: (2016)

Modified Alginate-Based Hydrogel as a Carrier of the CB2 Agonist JWH133 for Bone Engineering
por: Zhou, Wei, et al.
Publicado: (2021)

Time-Dependent Protection of CB2 Receptor Agonist in Stroke
por: Yu, Seong-Jin, et al.
Publicado: (2015)

Cannabinoid CB1 receptor agonist ACEA alleviates brain ischemia/reperfusion injury via CB1–Drp1 pathway
por: Yang, Shuai, et al.
Publicado: (2020)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
por: Ibsen, Mikkel Søes, et al.
Publicado: (2019)

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
por: Polini, Beatrice, et al.
Publicado: (2020)

Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
por: Franks, Lirit N., et al.
Publicado: (2016)

Evaluation of carboxamide-type synthetic cannabinoids as CB(1)/CB(2) receptor agonists: difference between the enantiomers
por: Doi, Takahiro, et al.
Publicado: (2017)

AM1241 alleviates MPTP-induced Parkinson's disease and promotes the regeneration of DA neurons in PD mice
por: Shi, Jun, et al.
Publicado: (2017)

Delivery of Human EV71 Receptors by Adeno-Associated Virus Increases EV71 Infection-Induced Local Inflammation in Adult Mice
por: Hsiao, Hung-Bo, et al.
Publicado: (2014)

Altered pain sensitivity in 5×familial Alzheimer disease mice is associated with dendritic spine loss in anterior cingulate cortex pyramidal neurons
por: Cui, Zhengyu, et al.
Publicado: (2022)

Computational Prediction and Biochemical Analyses of New Inverse Agonists for the CB1 Receptor
por: Scott, Caitlin E., et al.
Publicado: (2015)

Cannabinoid receptor subtype 2 (CB(2)R) agonist, GW405833 reduces agonist-induced Ca(2+) oscillations in mouse pancreatic acinar cells
por: Huang, Zebing, et al.
Publicado: (2016)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Enhanced photocytotoxicity of curcumin delivered by solid lipid nanoparticles
por: Jiang, Shan, et al.
Publicado: (2016)

Analgesic effect of a mixed T-type channel inhibitor/CB(2) receptor agonist
por: Gadotti, Vinicius M, et al.
Publicado: (2013)

CB2 Agonist (AM1241) Improving Effect on Ovalbumin-Induced Asthma in Rats
por: Parlar, Ali, et al.
Publicado: (2020)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

Coupling of CB-2 and CB-1
por: Ansaldo
Publicado: (2003)

The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson’s Disease
por: Yu, Hao, et al.
Publicado: (2021)

Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018)

Neuronal-Derived EV Biomarkers Track Cognitive Decline in Alzheimer’s Disease
por: Eren, Erden, et al.
Publicado: (2022)

Induction of SOCS Expression by EV71 Infection Promotes EV71 Replication
por: Gao, Wenying, et al.
Publicado: (2020)

Effects of the cannabinoid CB(1) agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs
por: Berger, Joel I., et al.
Publicado: (2017)

Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB(2) receptor agonist ABK5
por: Tang, Yaliang, et al.
Publicado: (2020)

Characterization of Subtype Selective Cannabinoid CB(2) Receptor Agonists as Potential Anti-Inflammatory Agents
por: Tang, Yaliang, et al.
Publicado: (2021)

CB(2) Cannabinoid Receptor As Potential Target against Alzheimer's Disease
por: Aso, Ester, et al.
Publicado: (2016)

Cannabinoid CB(2) receptors in the mouse brain: relevance for Alzheimer’s disease
por: López, Alicia, et al.
Publicado: (2018)

Extracellular Vesicles (EVs) and Pancreatic Cancer: From the Role of EVs to the Interference with EV-Mediated Reciprocal Communication
por: Moeng, Sokviseth, et al.
Publicado: (2020)

Serological detection and analysis of anti-VP1 responses against various enteroviruses (EV) (EV-A, EV-B and EV-C) in Chinese individuals
por: Gao, Caixia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pfe0eca05aq1fmqqtofcghatdn